European Journal of Cancer
Volume 41, Issue 17 , Pages 2637-2644 , November 2005

Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer

  • A.C. Voogd

      Affiliations

    • Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 43 3882387; fax: +31 433884128.
  • ,
  • F.J. van Oost

      Affiliations

    • Comprehensive Cancer Centre South, Eindhoven, The Netherlands
  • ,
  • E.J.T. Rutgers

      Affiliations

    • Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • ,
  • P.H.M. Elkhuizen

      Affiliations

    • Department of Radiotherapy, Free University Medical Centre, Amsterdam, The Netherlands
  • ,
  • A.N. van Geel

      Affiliations

    • Department of Surgery, Erasmus Medical Centre/Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
  • ,
  • L.J.E.E. Scheijmans

      Affiliations

    • Dr. Bernard Verbeeten Institute, Tilburg, The Netherlands
  • ,
  • M.J.C. van der Sangen

      Affiliations

    • Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands
  • ,
  • G. Botke

      Affiliations

    • Radiotherapeutisch Instituut Friesland, Leeuwarden, The Netherlands
  • ,
  • C.J. Hoekstra

      Affiliations

    • Radiotherapeutisch Instituut Stedendriehoek, Deventer, The Netherlands
  • ,
  • J.J. Jobsen

      Affiliations

    • Medisch Spectrum Twente, Enschede, The Netherlands
  • ,
  • C.J.H. van de Velde

      Affiliations

    • Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands
  • ,
  • M.F. von Meyenfeldt

      Affiliations

    • Department of Surgery, Academic Hospital Maastricht, The Netherlands
  • ,
  • J.M. Tabak

      Affiliations

    • Zeeuws Radiotherapeutisch Instituut, Vlissingen, The Netherlands
  • ,
  • J.L. Peterse

      Affiliations

    • Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • ,
  • M.J. van de Vijver

      Affiliations

    • Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • ,
  • J.W.W. Coebergh

      Affiliations

    • Comprehensive Cancer Centre South, Eindhoven, The Netherlands
    • Erasmus University Medical Centre, Department of Public Health, Rotterdam, The Netherlands
  • ,
  • G. van Tienhoven

      Affiliations

    • Department of Radiotherapy, Academic Medical Centre, Amsterdam, The Netherlands
  • ,
  • for the Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group)

Received 9 February 2005 ,Revised 6 April 2005 ,Accepted 8 April 2005.

References 

  1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–1232
  2. Arriagada R, Le MG, Guinebretiere JM, et al. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol. 2003;14(11):1617–1622
  3. Fredriksson I, Liljegren G, Arnesson L, et al. Local recurrence in the breast after conservative surgery-a study of prognosis and prognostic factors in 391 women. Eur J Cancer. 2002;38(14):1860
  4. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys. 1989;17(4):719–725
  5. Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989;63(10):1912–1917
  6. Elkhuizen PH, van de Vijver MJ, Hermans J, et al. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys. 1998;40(4):859–867
  7. Kemperman H, Borger J, Hart A, et al. Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence. Eur J Cancer. 1995;31A(5):690–698
  8. Krauss DJ, Kestin LL, Mitchell C, et al. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys. 2004;60(3):731–740
  9. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567–575
  10. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92(14):1143–1150
  11. Clark RM, Wilkinson RH, Mahoney LJ, et al. Breast cancer: a 21 year experience with conservative surgery and radiation. Int J Radiat Oncol Biol Phys. 1982;8(6):967–979
  12. Clarke DH, Le MG, Sarrazin D, et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1985;11(1):137–145
  13. Calle R, Vilcoq JR, Zafrani B, et al. Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys. 1986;12(6):873–878
  14. Haffty BG, Carter D, Flynn SD, et al. Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. Int J Radiat Oncol Biol Phys. 1993;27(3):575–583
  15. van Tienhoven G, Voogd AC, Peterse JL, et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer. 1999;35(1):32–38
  16. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991;338(8763):327–331
  17. Whelan T, Clark R, Roberts R, et al. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys. 1994;30(1):11–16
  18. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995;87(1):19–27
  19. Francis M, Cakir B, Ung O, et al. Prognosis after breast recurrence following conservative surgery and radiotherapy in patients with node-negative breast cancer. Br J Surg. 1999;86(12):1556–1562
  20. Haffty BG, Reiss M, Beinfield M, et al. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol. 1996;14(1):52–57
  21. Fortin A, Larochelle M, Laverdiere J, et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 1999;17(1):101–109
  22. Voogd AC, van Tienhoven G, Peterse HL, et al. Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Cancer. 1999;85(2):437–446
  23. Rauschecker H, Clarke M, Gatzemeier W, et al. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev. 2001;(4):CD002195
  24. Haffty BG, Fischer D, Beinfield M, et al. Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys. 1991;21(2):293–298
  25. Huang E, Buchholz TA, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer. 2002;95(10):2059–2067
  26. Smith TE, Lee D, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys. 2000;48(5):1281–1289
  27. Gage I, Schnitt SJ, Recht A, et al. Skin recurrences after breast-conserving therapy for early-stage breast cancer. J Clin Oncol. 1998;16(2):480–486
  28. Kurtz JM, Spitalier JM, Amalric R, et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1990;18(1):87–93
  29. Le MG, Arriagada R, Spielmann M, et al. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma. Cancer. 2002;94(11):2813–2820
  30. Elkhuizen PH, Hermans J, Leer JW, et al. Isolated late local recurrences with high mitotic count and early local recurrences following breast-conserving therapy are associated with increased risk on distant metastasis. Int J Radiat Oncol Biol Phys. 2001;50(2):387–396
  31. Fowble B, Solin LJ, Schultz DJ, et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 1990;19(4):833–842
  32. Regitnig P, Moser R, Thalhammer M, et al. Microsatellite analysis of breast carcinoma and corresponding local recurrences. J Pathol. 2002;198(2):190–197
  33. Schlechter BL, Yang Q, Larson PS, et al. Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. J Clin Oncol. 2004;22(10):1830–1838
  34. Abner AL, Recht A, Eberlein T, et al. Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1993;11(1):44–48
  35. Haffty BG, Toth M, Flynn S, et al. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient. J Clin Oncol. 1992;10(12):1839–1847

PII: S0959-8049(05)00548-4

doi: 10.1016/j.ejca.2005.04.040

European Journal of Cancer
Volume 41, Issue 17 , Pages 2637-2644 , November 2005